Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis.
J Clin Oncol
; 26(20): 3358-63, 2008 Jul 10.
Article
in En
| MEDLINE
| ID: mdl-18519952
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Bone Marrow Cells
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Clin Oncol
Year:
2008
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United States